Xanthine oxidase inhibitors in cardiovascular disease: impact on mortality and ATP dynamics

Back

ESC2025 Premium Access

Xanthine oxidase inhibitors in cardiovascular disease: impact on mortality and ATP dynamics

Session: Basic concepts in heart failure

Topic: Pharmacotherapy

Speaker: Associate Professor M. Kuwabara (Shimotsuke, JP)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Masanari Kuwabara

Jichi Medical University, Shimotsuke (Japan)

1 presentation

1 follower

6 more presentations in this session

Effect of qiliqiangxin according to N-terminal pro-B-type natriuretic peptide in patients with heart failure and reduced ejection fraction: insights from QUEST

Speaker: Doctor L. Shen (Glasgow, CN)

Dystrophin cleavage affects the entire membranous dystrophin complex and leads to cardiomyocyte cell death and heart failure

Speaker: Doctor F. Krizanic (Neuruppin, DE)

Feasibility of a novel implantable device to provide heart failure therapy and left atrial pressure monitoring in a chronic animal study

Speaker: Doctor S. Ge (Shanghai, CN)

Beneficial effects of treatment with a soluble guanylate cyclase stimulator on cardiac function and mitochondrial activity in an animal model of early-stage HFpEF

Speaker: Mr X. Vazquez-Abuin (Santiago De Compostela, ES)

Amyloid-beta metabolism, cardiac remodeling and myocardial recovery in advanced heart failure

Speaker: Doctor G. Zervas (Athens, GR)

Access the full session

Basic concepts in heart failure

Speakers: Associate Professor M. Kuwabara, Doctor L. Shen, Doctor F. Krizanic, Doctor S. Ge, Mr X. Vazquez-Abuin...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources